黄芪甲苷调控Akt信号通路阻抑人腹膜间皮细胞间充质转化的实验研究

俞曼殊; 史俊; 赵君谊; 朱羿霖; 盛梅笑

黄芪甲苷调控Akt信号通路阻抑人腹膜间皮细胞间充质转化的实验研究

南京中医药大学附属医院，江苏南京 210029

计量
- 文章访问数: 772
- HTML全文浏览量: 4
- PDF下载量: 766
- 被引次数: 0
出版历程
- 刊出日期: 2019-01-10

The Inhibitory Effect of Astragaloside Ⅳ on Epithelial Mesenchymal Transition of Human Peritoneal Mesothelial Cells by Regulating Akt Signaling

摘要

摘要: 目的观察黄芪甲苷（AS-Ⅳ）对TGF-β1诱导人腹膜间皮细胞HMrSV5 EMT及β-catenin的影响，探讨Akt信号通路的作用及AS-Ⅳ干预机制。方法采用TGF-β1诱导建立HMrSV5 EMT模型，Western blot检测不同浓度TGF-β1对EMT标记蛋白、β-catenin及Akt信号蛋白的影响；予不同浓度AS-Ⅳ干预HMrSV5 EMT模型，Real-time PCR检测EMT相关基因及β-catenin mRNA水平，Western blot检测Akt信号蛋白表达；与Akt通路抑制剂MK2206、雷帕霉素及激动剂Insulin作对照，观察AS-Ⅳ干预HMrSV5 EMT指标及β-catenin蛋白的变化。结果 ①TGF-β1诱导HMrSV5细胞发生EMT、上调β-catenin水平，激活Akt信号通路；②AS-Ⅳ能不同程度改善TGF-β1诱导的HMrSV5 EMT、降解β-catenin，并在一定程度上抑制Akt信号通路活化；③Akt通路参与调控HMrSV5 EMT及β-catenin，其抑制剂MK2206、雷帕霉素的调控作用与AS-Ⅳ类似；④Akt通路激动剂Insulin明显减弱AS-Ⅳ对EMT及β-catenin的抑制效果。结论 TGF-β1可诱导HMrSV5 EMT，上调β-catenin，AS-Ⅳ可能通过抑制Akt信号通路活化，阻抑HMrSV5 EMT，降解β-catenin。
- 黄芪甲苷 /
- 腹膜纤维化 /
- 上皮间充质转化 /
- Akt信号通路
Abstract: OBJECTIVE To observe the effect of Astragaloside Ⅳ (AS-Ⅳ) on EMT of human peritoneal mesothelial cells (HPMCs) HMrSV5， exploring the function of Akt signaling and regulatory mechanism of AS-Ⅳ. METHODS We used TGF-β1 to establish EMT model of HMrSV5. EMT marker proteins， β-catenin and Akt signaling-related proteins were detected by Western blotting analysis. β-catenin and EMT-related mRNA were expressed by Real-time PCR analysis. Compared with MK2206， Rapamycin and Insulin， the effect of AS-Ⅳ on EMT and β-catenin was observed by Western blotting. RESULTS ①The EMT model of HMrSV5 was established by TGF-β1. TGF-β1 increased β-catenin expression and activated Akt signaling. ②AS-Ⅳ could alleviate TGF-β1-treated EMT of HMrSV5， decrease β-catenin expression， as well as inhibit activation of Akt signaling. ③EMT of HMrSV5 and β-catenin were regulated by Akt signaling， MK2206 and Rapamycin had the similar effect with AS-Ⅳ. ④Insulin could reduce obviously inhibitory effect on EMT and β-catenin of AS-Ⅳ. CONCLUSION TGF-β1 can induce EMT of HMrSV5 and upregulate β-catenin， AS-Ⅳ has inhibitory effect on EMT and β-catenin of HMrSV5 by regulating Akt signaling.
- Astragaloside Ⅳ /
- peritoneal fibrosis /
- epithelial-mesenchymal transition /
- Akt signaling pathway

HTML全文

参考文献(17)

[1]	MEHROTRA R， DEVUYST O， DAVIES SJ， et al. The current state of peritoneal dialysis[J]. J Am Soc Nephrol， 2016， 27: 3238-3252.
[2]	YAEZ-MO M， LARA-PEZZI E， SELGAS R， et al. Peritoneal dialysis and epithelial-to-mesenchymal transition of mesothelial cells[J]. N Engl J Med， 2003， 348(5): 403-413.
[3]	史俊，俞曼殊，盛梅笑，等. 黄芪甲苷抑制高糖腹透液诱导HMrSV5氧化应激与EMT的实验研究[J]. 南京中医药大学学报， 2016， 32(4): 337-341.
[4]	YOSHIZAWA H， MORISHITA Y， WATANABE M， et al. TGF-β 1-siRNA delivery with nanoparticles inhibits peritoneal fibrosis[J]. Gene Ther， 2015， 22(4): 333.
[5]	HUANG TS， LI L， MOALIM‐NOUR L， et al. A regulatory network involving β‐Catenin， E-cadherin， PI3k/Akt， and Slug balances self‐renewal and differentiation of human pluripotent stem cells in response to wnt signaling[J]. Stem Cell， 2015， 33(5): 1419-1433.
[6]	ZHOU D， TAN RJ， FU H， et al. Wnt/β-catenin signaling in kidney injury and repair: a double-edged sword[J]. Lab Invest， 2016， 96(2): 156-167.
[7]	BAO Z， XU X， LIU Y， et al. CBX7 negatively regulates migration and invasion in glioma via Wnt/β-catenin pathway inactivation[J]. Oncotarget， 2017， 8(24): 39048-39063.
[8]	GUO Y， GUPTE M， UMBARKAR P， et al. Entanglement of GSK-3β， β-catenin and TGF-β1 signaling network to regulate myocardial fibrosis[J]. J Mol Cell Cardiol， 2017， 110: 109.
[9]	LIEN EC， LYSSIOTIS CA， CANTLEY LC. Metabolic reprogramming by the PI3K-Akt-mTOR pathway in cancer[J]. Metab Cancer， 2016:39-72.
[10]	MATSUMOTO T， YOKOI A， HASHIMURA M， et al. TGF-β-mediated LEFTY/Akt/GSK-3β/Snail axis modulates epithelial-mesenchymal transition and cancer stem cell properties in ovarian clear cell carcinomas[J]. Mol Carcinogen， 2018， 57(8):957-967.
[11]	YU D， LEI JQ， GUO SL， et al. The CNPY2 enhances epithelial-mesenchymal transition via activating the AKT/GSK3β pathway in non-small cell lung cancer[J]. Cell Biol Int， 2018， 42(8):959-964.
[12]	BACHELDER RE， YOON SO， FRANCI C， et al. Glycogen synthase kinase-3 is an endogenous inhibitor of Snail transcription: implications for the epithelial mesenchymal transition[J]. J Cell Biol， 2005， 168(1): 29-33.
[13]	WANG H， ZHANG G， ZHANG H， et al. Acquisition of epithelial–mesenchymal transition phenotype and cancer stem cell-like properties in cisplatin-resistant lung cancer cells through AKT/β-catenin/Snail signaling pathway[J]. Eur J Pharmacol， 2014， 723: 156-166.
[14]	WU K， FAN J， ZHANG L， et al. PI3K/Akt to GSK3β/β-catenin signaling cascade coordinates cell colonization for bladder cancer bone metastasis through regulating ZEB1 transcription[J]. Cell Signal， 2012， 24(12): 2273-2282.
[15]	WALKER NM， BELLOLI EA， STUCKEY L， et al. Mechanistic target of rapamycin complex 1 (mTORC1) and mTORC2 as key signaling intermediates in mesenchymal cell activation[J]. J Biol Chem， 2016， 291(12): 6262-6271.
[16]	LAMOUILLE S， CONNOLLY E， SMYTH JW， et al. TGF-β-induced activation of mTOR complex 2 drives epithelial-mesenchymal transition and cell invasion[J]. J Cell Sci， 2012， 125(5): 1259-1273.
[17]	HAN Q， LIN L， ZHAO B， et al. Inhibition of mTOR ameliorates bleomycin-induced pulmonary fibrosis by regulating epithelial-mesenchymal transition[J]. Biochem Bioph Res Comm， 2018， 500(4): 839-845.